Routine evaluation of sampling practices and sample integrity undertaken prior to the ASX announcement of 21st July 2016 did not identify any significant issues with sample quality. As specified in Table 1 of that announcement, RC samples from SPBC0313 comprised both dry and wet samples. Checking of this indicated there was no consistent relationship between sample contamination, wetness, or recovery with grade (which if present may suggest the possibility of contamination, smearing, dilution or upgrading), and a subsequent review has reaffirmed this. Likewise, routine QAQC evaluation of laboratory assays undertaken prior to the ASX announcement of 21st July 2016 did not identify any significant issues with the analytical accuracy and precision. As specified in Table 1 of that announcement, the accuracy and precision of assays of samples from SPBC0313 were checked using certified reference standards, duplicates and blanks. Checking of this indicated that all assays were within acceptable limits of accuracy and precision, and a subsequent review has reaffirmed this.
@bobminer, What does this mean in your view? Thanks
- Forums
- ASX - By Stock
- S2R
- Ann: Monsoon Drilling Update-S2R.AX
Ann: Monsoon Drilling Update-S2R.AX, page-49
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add S2R (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.1¢ |
Change
0.001(1.43%) |
Mkt cap ! $31.24M |
Open | High | Low | Value | Volume |
7.0¢ | 7.4¢ | 6.9¢ | $37.45K | 524.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 7.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.1¢ | 21162 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.070 |
1 | 38546 | 0.069 |
1 | 160000 | 0.068 |
2 | 50000 | 0.067 |
2 | 64000 | 0.065 |
Price($) | Vol. | No. |
---|---|---|
0.071 | 21162 | 2 |
0.072 | 99902 | 1 |
0.074 | 80000 | 1 |
0.075 | 215219 | 1 |
0.077 | 10000 | 1 |
Last trade - 12.23pm 12/11/2024 (20 minute delay) ? |
Featured News
S2R (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online